Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Radiology

Getting an Accurate Diagnosis: Imaging and Mimics

At a Glance

Most liver hemangiomas can be diagnosed without a biopsy because MRI, CT, or contrast-enhanced ultrasound shows how contrast moves through the blood-vessel cluster. If the pattern is unusual, doctors use more imaging and medical history to rule out cancer.

Because a liver hemangioma is a cluster of blood vessels, it has a distinct “signature” when viewed through medical imaging. In most cases, a radiologist can identify a hemangioma with high confidence using non-invasive scans, avoiding the need for more invasive tests like a biopsy [1][2].

The Role of Contrast Imaging

While a standard ultrasound is often the first tool to spot a liver lesion, it usually cannot confirm a hemangioma on its own. To get a definitive diagnosis, doctors rely on contrast-enhanced scans, such as a multiphasic CT, MRI, or Contrast-Enhanced Ultrasound (CEUS) [1][3]. These tests use a special dye (contrast) injected into a vein to show how blood flows through the liver in real-time. MRI is often highly preferred for its ability to characterize liver tissue, but CT or CEUS are excellent alternatives depending on availability, kidney function, and patient specific needs.

Radiologists look for a specific pattern called centripetal filling:

  1. Peripheral Nodular Enhancement: In the first few seconds (the arterial phase), the contrast dye appears as bright “dots” or nodules only around the outer edges of the hemangioma [4][3].
  2. Progressive Fill-in: Over the next few minutes, the dye slowly moves from the edges toward the center of the growth [4][5].
  3. Persistence: Unlike many cancerous tumors that “wash out” (clear the dye quickly), a typical hemangioma holds onto the contrast for a long time [3][6].

When a Hemangioma is “Atypical”

Not every hemangioma follows the classic rules. Some are labeled “atypical” because they look different on a scan, which can make them harder to distinguish from other liver lesions.

  • Flash-Filling Hemangiomas: Very small hemangiomas may fill with blood so quickly that they light up all at once, appearing similar to some types of liver cancer [5][7].
  • Sclerosed Hemangiomas: These are older, degenerating hemangiomas where the blood vessels have been heavily replaced by scar tissue (fibrosis). They may not fill with contrast in the typical way, making them “mimics” of more serious conditions [8][9].
  • Giant Hemangiomas: Very large growths may have a central area that never fills with blood because of internal scarring or old clots [10][9].

Distinguishing Mimics

The primary goal of contrast imaging is to rule out malignant (cancerous) tumors that can sometimes mimic an atypical hemangioma. These include:

  • Hepatocellular Carcinoma (HCC): The most common primary liver cancer, often seen in people with cirrhosis or chronic hepatitis [7][6].
  • Metastases: Cancer that has spread to the liver from another organ, such as the colon or breast [11][6].
  • Intrahepatic Cholangiocarcinoma: A cancer of the bile ducts within the liver [12][13].
  • Angiosarcoma: A very rare, aggressive cancer of the blood vessels [14][15].

Radiologists look for “red flags” that suggest a mimic, such as irregular or “infiltrative” margins, rapid growth, or a “washout” pattern where the contrast dye disappears quickly [14][16].

Why Biopsies are Rarely Used

In many parts of the body, a biopsy (using a needle to take a tissue sample) is the standard way to diagnose a tumor. However, for a suspected liver hemangioma, doctors try to avoid this primarily because of bleeding risk. Because a hemangioma is essentially a collection of thin-walled blood vessels, sticking a needle into it can cause significant internal bleeding [17][18].

Additionally, modern imaging is usually so effective that a biopsy is simply unnecessary. A biopsy is typically only performed if multiple high-quality imaging scans are still “indeterminate” and an expert multidisciplinary liver team decides they must rule out cancer to safely plan your care [1][12]. An indeterminate scan does not automatically mean you need a biopsy or surgery.

Common questions in this guide

How do doctors confirm that a liver lesion is a hemangioma?
Doctors usually use contrast-enhanced imaging rather than biopsy. MRI, multiphasic CT, or contrast-enhanced ultrasound can show how contrast moves through the lesion, while a standard ultrasound may only detect it without confirming the diagnosis.
What does centripetal filling mean on a liver scan?
Centripetal filling is a typical hemangioma pattern in which contrast first appears in nodules along the outer edge and then gradually moves toward the center. The contrast often remains visible instead of quickly disappearing, which helps distinguish a hemangioma from some cancerous tumors.
Can an atypical liver hemangioma look like cancer?
Yes. Very small flash-filling hemangiomas, scarred sclerosed hemangiomas, and very large hemangiomas can have unusual imaging patterns that resemble cancer. Radiologists consider the lesion’s margins, growth, contrast behavior, and your medical history when evaluating these possibilities.
Why is a biopsy usually avoided for a suspected liver hemangioma?
A hemangioma contains thin-walled blood vessels, so inserting a needle can cause significant bleeding. When high-quality imaging is characteristic, a biopsy is unnecessary; it may be considered only when scans remain indeterminate and a multidisciplinary liver team believes tissue testing is needed.
Would an MRI or contrast-enhanced ultrasound clarify my liver hemangioma diagnosis?
Possibly. MRI is often preferred for characterizing liver tissue, while contrast-enhanced ultrasound and multiphasic CT can be useful alternatives. The best test depends on the initial findings, availability, kidney function, contrast considerations, and your individual medical needs.
Does my history of cirrhosis, hepatitis, or cancer affect how the scan is interpreted?
Yes. Cirrhosis, chronic hepatitis, and a history of cancer can change the likelihood of other liver tumors, such as hepatocellular carcinoma or metastases. Make sure the radiology team knows your complete medical history so the imaging findings can be interpreted in context.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my imaging show the classic 'peripheral nodular enhancement' and 'centripetal filling' pattern?
  2. 2.Are there any 'atypical' features, like irregular margins or restricted diffusion, that make you concerned about a mimic?
  3. 3.Would an MRI or a contrast-enhanced ultrasound (CEUS) provide more clarity than my initial scan?
  4. 4.Given my medical history, what is the likelihood that this could be a different type of tumor, like HCC or a metastasis?
  5. 5.If the diagnosis is still 'indeterminate' or 'atypical,' what is our plan for monitoring or further testing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    One stop shop approach for the diagnosis of liver hemangioma.

    Sandulescu LD, Urhut CM, Sandulescu SM, et al.

    World journal of hepatology 2021; (13(12)):1892-1908 doi:10.4254/wjh.v13.i12.1892.

    PMID: 35069996
  2. 2

    Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.

    Dietrich CF, Nolsøe CP, Barr RG, et al.

    Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2020; (41(5)):562-585 doi:10.1055/a-1177-0530.

    PMID: 32707595
  3. 3

    Spontaneous regression of a giant hepatic hemangioma on serial MRI: A case report with 3-year follow-up.

    Qirinxhi D, Çela D, Saraci B, Bilaj F

    Radiology case reports 2026; (21(10)):4869-4873 doi:10.1016/j.radcr.2026.06.162.

    PMID: 42564742
  4. 4

    Isolated hepatic hemangiomatosis in 2 septuagenarians.

    Liu MC, Little EC

    Radiology case reports 2018; (13(6)):1097-1103 doi:10.1016/j.radcr.2018.08.018.

    PMID: 30233736
  5. 5

    Can Dynamic Contrast-Enhanced MRI Be Used to Differentiate Hepatic Hemangioma from Other Lesions in Early Infancy?

    Halevy D, Sayed BA, Shaikh F, et al.

    The Indian journal of radiology & imaging 2024; (34(4)):612-619 doi:10.1055/s-0044-1785208.

    PMID: 39318559
  6. 6

    A Study on the Characteristics of Sonazoid Contrast-Enhanced Ultrasound in the Transitional Phase for Common Focal Liver Lesions and Its Value in Differential Diagnosis.

    Luo Y, Wen D, Zhang J, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2026; (45(6)):1235-1245 doi:10.1002/jum.70162.

    PMID: 41439463
  7. 7

    Hepatic hemangiomas: the various imaging avatars and its mimickers.

    Mathew RP, Sam M, Raubenheimer M, et al.

    La Radiologia medica 2020; (125(9)):801-815 doi:10.1007/s11547-020-01185-z.

    PMID: 32249391
  8. 8

    Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor.

    Kim YY, Kang TW, Cha DI, et al.

    European journal of radiology 2021; (135()):109474 doi:10.1016/j.ejrad.2020.109474.

    PMID: 33352374
  9. 9

    A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography.

    Akahoshi S, Yamamura K, Sato N, et al.

    Clinical journal of gastroenterology 2020; (13(6)):1252-1257 doi:10.1007/s12328-020-01194-5.

    PMID: 32705537
  10. 10

    Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.

    Jia C, Liu G, Wang X, et al.

    Japanese journal of radiology 2021; (39(11)):1059-1068 doi:10.1007/s11604-021-01139-z.

    PMID: 34041675
  11. 11

    Multiple hepatic sclerosing hemangioma mimicking metastatic liver tumor successfully treated by laparoscopic surgery: Report of a case.

    Wakasugi M, Ueshima S, Tei M, et al.

    International journal of surgery case reports 2015; (8C()):137-40.

    PMID: 25679307
  12. 12

    Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report.

    Lin S, Zhang L, Li M, et al.

    Medicine 2017; (96(50)):e9192 doi:10.1097/MD.0000000000009192.

    PMID: 29390333
  13. 13

    Simultaneous degenerative changes in 2 hepatic cavernous hemangiomas observed over 23 years of follow-up: A case report and review of the literature.

    Kawaguchi T, Arinaga-Hino T, Tanoue S, et al.

    Radiology case reports 2026; (21(1)):343-348 doi:10.1016/j.radcr.2025.09.089.

    PMID: 41245058
  14. 14

    Evaluation of Primary Liver Cancers Using Hepatocyte-Specific Contrast-Enhanced MRI: Pitfalls and Potential Tips.

    Kim JH, Yoon JH, Joo I, Lee JM

    Journal of magnetic resonance imaging : JMRI 2021; (53(3)):655-675 doi:10.1002/jmri.27213.

    PMID: 32700807
  15. 15

    Primary hepatic angiosarcoma mistaken for a giant hemangioma.

    Qian XJ, Girgis S, Wilson MP, Low G

    Intractable & rare diseases research 2025; (14(1)):85-87 doi:10.5582/irdr.2024.01045.

    PMID: 40046027
  16. 16

    Use of the Term "Atypical Hepatic Hemangioma" in Radiology Reports: An Analysis of Diagnostic Precision.

    Tamir S, Krutik T, Kedem Mashraki R, et al.

    Journal of clinical medicine 2026; (15(15)) doi:10.3390/jcm15155923.

    PMID: 42590025
  17. 17

    Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab.

    Zhang C, Wang G, Liu N, et al.

    Frontiers in immunology 2024; (15()):1387465 doi:10.3389/fimmu.2024.1387465.

    PMID: 38646529
  18. 18

    Two hepatic cavernous hemangiomas mimicking colorectal liver metastasis: A rare case report.

    Alsofyani TM, Aldossary MY, AlQahtani FF, et al.

    International journal of surgery case reports 2021; (81()):105817 doi:10.1016/j.ijscr.2021.105817.

    PMID: 33774442

This page is for informational purposes only and does not constitute medical advice. It explains imaging for a suspected liver hemangioma; discuss your results and next steps with your radiologist or liver specialist.

Get notified when new evidence is published on liver hemangioma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.